LFG
ABOS icon

Larson Financial Group’s Acumen Pharmaceuticals ABOS Stock Holding History

Larson Financial Group’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47 Sell
20
-4,328
-100% -$11K ﹤0.01% 3548
2025
Q4 		$9.17K Buy
4,348
+348
+9% +$690 ﹤0.01% 2164
2025
Q3 		$6.84K Buy
+4,000
New +$5.54K ﹤0.01% 2219

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Larson Financial Group's ABOS Position: Q1 2026 in Review

Larson Financial Group reduced its Acumen Pharmaceuticals (ABOS) stake by 100% in Q1 2026, selling an estimated $11K and leaving 20 shares worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #3548.

Larson Financial Group first reported a position in ABOS in Q3 2025 and has held it in 3 quarters since. The position peaked at $9.17K in Q4 2025. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • Larson Financial Group held 20 shares of Acumen Pharmaceuticals worth $47 as of Q1 2026.
  • Larson Financial Group sold 4,328 Acumen Pharmaceuticals shares in Q1 2026, an estimated $11K.
  • Acumen Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3548 holding.
  • Larson Financial Group first reported a position in Acumen Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Larson Financial Group's Acumen Pharmaceuticals position peaked at $9.17K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.